Abstract
Systemic sclerosis is an autoimmune disease characterized by T-cell infiltration in the skin that leads to fibrosis, which can be life-limiting. Although T cells are important, it is not known which types mediate the fibrosis. The work presented by Li et al shows that memory CD8(+) cytotoxic T cells mediate fibrosis via the secretion of IL-13. IL-13 is profibrotic, and it is released in a higher amount in patients with systemic sclerosis. This suggests that targeting IL-13 may be therapeutically beneficial.
| Original language | English |
|---|---|
| Pages (from-to) | 1003-1004 |
| Number of pages | 2 |
| Journal | Journal of Investigative Dermatology |
| Volume | 137 |
| Issue number | 5 |
| Early online date | 12 Apr 2017 |
| DOIs | |
| Publication status | Published - 1 May 2017 |
Keywords
- Fibrosis
- Humans
- Interleukin-13
- Scleroderma, Systemic
- Skin
- Journal Article